NCT05646056View on ClinicalTrials.gov

A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

CompletedOBSERVATIONAL

Enrollment

82

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

September 18, 2024

Study Completion Date

September 18, 2024

Conditions

Heart FailureCardiomyopathy, HypertrophicLeft Ventricular Hypertrophy

Interventions

DEVICE

Software

Observation only

Trial Locations (1)

32216

Jacksonville Center for Clinical Research, Jacksonville

All Listed Sponsors

lead

Prolaio

INDUSTRY